Claus Torp Jensen appointed as Chairperson of the Qureight Board
Qureight and Vicore Pharma release results characterising lung disease patients who may be more responsive to C21 treatment
Qureight collaborates with AstraZeneca on lung disease research
Dr Pilar Rivera-Ortega joins Qureight’s Scientific Advisory Board
Qureight is partnering with patientMpower to reveal AI insights for improved ILD care
Qureight today announces the appointment of Dr Xose Fernandez to its Scientific Advisory Board.
